FDA approves first generic for Amarin's Vascepa
Roche buys Stratos Genomics to improve diagnostic arm
AstraZeneca's COVID-19 vaccines enters phase 2/3 clinical trial
Intercept's NASH drug hits regulatory snag at FDA
please scroll down for all the latest news*